Novo Nordisk A/S

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +45

Novo Nordisk A/S - share repurchase programme - Chemocule

Share buyback AI-generated analysis

πŸ“ˆ Novo Nordisk launched a dedicated share repurchase program on May 6, 2026, targeting up to DKK 11.2 billion in B share buybacks.

πŸ’° As of October 9, 2026, the company has spent over DKK 10.5 billion to acquire approximately 37.85 million shares.

πŸ“Š The average purchase price for repurchased B shares was DKK 278.97 per share during the reporting period.

🏦 Novo Nordisk's current treasury holdings total 51,889,876 B shares, equivalent to 1.2% of the company's total share capital.

πŸ“… The broader share repurchase initiative covers a 12-month window starting from February 4, 2026, with a total cap of DKK 15 billion.

🌍 Novo Nordisk operates as a global healthcare leader with over 67,000 employees focused on treatments for lasting health.

Bullish Signals
  • Novo Nordisk is actively reducing its share count through a structured buyback program, having already spent over DKK 10.5 billion to acquire nearly 38 million shares as of October 2026.
  • The company holds a significant treasury stake of 1.2% (approx. 51.9 million shares), demonstrating confidence in its long-term value and commitment to capital return strategies.
Full Analysis
Novo Nordisk A/S initiated a specific share repurchase programme on May 6, 2026, authorizing the buyback of B shares up to DKK 11.2 billion between May 6 and February 1, 2027. This initiative is a component of a broader, larger-scale treasury stock program approved earlier in the year. As of October 9, 2026, Novo Nordisk has executed significant buybacks under this framework, purchasing approximately 37.85 million B shares at an average price of DKK 278.97 per share. These transactions have resulted in a total transaction value exceeding DKK 10.5 billion. Following these acquisitions, the company holds a treasury stake of 51,889,876 B shares, representing 1.2% of its total share capital. The aggregate number of A and B shares outstanding, including treasury shares, stands at 4.465 billion.